Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2283-2288

  Chavez Bueno, Susana ^a,d   Bozdogan, Bülent ^c,e   Katz, Kathy ^a   Bowlware, Karen L ^a,f   Cushion, Nancy ^a   Cavuoti, Dominick ^b   Ahmad, Naveed ^b   McCracken Jr , George H ^a   Appelbaum, Peter C ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d Institut Pasteur ^*  (United States)

^e INSTITUT PASTEUR   (France)

^f UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; CORYNEBACTERIUM STRIATUM; ERM GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MSR GENE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TREATMENT FAILURE; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HUMANS; INFANT; INFANT, NEWBORN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEXAS;

EID: 19544378515     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2283-2288.2005     Document Type: Article

References (32)

1. Abi-Hanna, P., A. L. Frank, J. P. Quinn, S. Kelkar, P. C. Schreckenberger, M. K. Hayden, and J. F. Marcinak. 2000. Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children. Clin. Infect. Dis. 30:630-631.
2. Almer, L. S., V. D. Shortridge, A. M. Nilius, J. M. Beyer, N. B. Soni, M. H. Bui, G. G. Stone, and R. K. Flamm. 2002. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 43:225-232.
3. Avalos Mishaan, A. M., E. O. Mason, G. Martinez-Aguilar, W. Hammerman, J. J. Propst, J. R. Lupski, P. Stankiewicz, S. L. Kaplan, and K. Hulten. 2005. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr. Infect. Dis. J. 24:201-206.
4. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
5. Buckingham, S. C., L. K. McDougal, L. D. Cathey, K. Comeaux, A. S. Craig, S. K. Fridkin, and F. C. Tenover. 2004. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr. Infect. Dis. J. 23:619-624.
6. Centers for Disease Control and Prevention. 20 August 1999, posting date. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. Morb. Mortal. Wkly. Rep. 48:707-710. [Online.] http://www.cdc.gov.
7. Fergie, J. E., and K. Purcell. 2001. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr. Infect. Dis. J. 20:860-863.
8. Frank, A. L., J. F. Marcinak, P. D. Mangat, and P. C. Schreckenberger. 1999. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 18:993-1000.
9. Frank, A. L., J. F. Marcinak, P. D. Mangat, and P. C. Schreckenberger. 1999. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin. Infect. Dis. 29:935-936.
10. Frank, A. L., J. F. Marcinak, P. D. Mangat, J. T. Tjhio, S. Kelkar, P. C. Schreckenberger, and J. P. Quinn. 2002. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-534.
11. Garcia-Key, C., L. Aguilar, F. Baquero, J. Casal, and J. E. Martin. 2002. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J. Clin. Microbiol. 40:2959-2963.
12. Herold, B. C., L. C. Immergluck, M. C. Maranan, D. S. Lauderdale, R. E. Gaskin, S. Boyle-Vavra, C. D. Leitch, and R. S. Daum. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598.
13. Hussain, F. M., S. Boyle-Vavra, C. D. Bethel, and R. S. Daum. 2000. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr. Infect. Dis. J. 19:1163-1166.
14. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
15. Lee, M. C., A. M. Rios, M. F. Aten, A. Mejias, D. Cavuoti, G. H. McCracken, Jr., and R. D. Hardy. 2004. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr. Infect. Dis. J. 23:123-127.
16. Lennette, E. H., A. Balows, W. J. Hansler, and H. J. Shadomy (ed.). 1995. Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
17. Marcinak, J. F., and A. L. Frank. 2003. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr. Opin. Infect. Dis. 16:265-269.
18. Martinez-Aguilar, G., A. Avalos-Mishaan, K. Hulten, W. Hammerman, E. O. Mason, Jr., and S. L. Kaplan. 2004. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr. Infect. Dis. J. 23:701-706.
19. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxaeillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
20. Mongkolrattanothai, K., S. Boyle, M. D. Kahana, and R. S. Daum. 2003. Severe Staphyloeoccus aureus infections caused by elonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin. Infect. Dis. 37:1050-1058.
21. Naimi, T. S., K. H. LeDell, D. J. Boxrud, A. V. Groom, C. D. Steward, S. K. Johnson, J. M. Besser, C. O'Boyle, R. N. Danila, J. E. Cheek, M. T. Osterholm, K. A. Moore, and K. E. Smith. 2001. Epidemiology and clonality of community-acquired methicillin-resistant Staphyloeoccus aureus in Minnesota, 1996-1998. Clin. Infect. Dis. 33:990-996.
22. Naimi, T. S., K. H. LeDell, K. Como-Sabetti, S. M. Borchardt, D. J. Boxrud, J. Etienne, S. K. Johnson, F. Vandenesch, S. Fridkin, C. O'Boyle, R. N. Danila, and R. Lynfield. 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976-2984.
23. NCCLS. 2004. Performance standards for antimicrobial susceptibility testing: 14th informational supplement. NCCLS document M100-S14. NCCLS, Wayne, Pa.
24. Saiman, L., M. O'Keefe, P. L. Graham III, F. Wu, B. Said-Salim, B. Kreiswirth, A. LaSala, P. M. Schlievert, and P. Della-Latta. 2003. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin. Infect. Dis. 37:1313-1319.
25. Sattler, C. A., E. O. Mason, Jr., and S. L. Kaplan. 2002. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21:910-917.
26. Schmitz, F. J., R. Sadurski, A. Kray, M. Boos, R. Geisel, K. Kohrer, J. Verhoef, and A. C. Fluit. 2000. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J. Antimicrob. Chemother. 45:891-894.
27. Shortridge, V. D., G. V. Doern, A. B. Brueggemann, J. M. Beyer, and R. K. Flamm. 1999. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clin. Infect. Dis. 29: 1186-1188.
28. Shukla, S. K., M. E. Stemper, S. V. Ramaswamy, J. M. Conradt, R. Reich, E. A. Graviss, and K. D. Reed. 2004. Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin. J. Clin. Microbiol. 42:3752-3757.
29. Stranden, A., R. Frei, and A. F. Widmer. 2003. Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis? J. Clin. Microbiol. 41:3181-3186.
30. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
31. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Weisblum, B., and V. Demohn. 1969. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J. Bacteriol. 98:447-452.